陳 海雯

Medicine & Life Sciences

1. Neoplasms 95%
2. Radiotherapy 92%
3. Platinum 91%
4. Copper Transporter 1 90%
5. Survival 72%
6. Copper Transport Proteins 66%
7. Argininosuccinate Synthase 58%
8. Drug Therapy 55%
9. Lung Neoplasms 50%
10. Nasopharyngeal Carcinoma 50%
11. Non-Small Cell Lung Carcinoma 50%
12. Starvation 48%
13. Malignant Pleural Effusion 39%
14. Adenocarcinoma of Lung 38%
15. Radiation 37%
16. Homeostasis 36%
17. Arginine 34%
18. Squamous Cell Carcinoma 33%
19. Therapeutics 32%
20. Carcinoma 28%
21. Loss of Heterozygosity 27%
22. Life Expectancy 26%
23. Nasopharyngeal Neoplasms 25%
24. Chelating Agents 21%
25. Pharmaceutical Preparations 21%
26. ADI PEG20 21%
27. T-Cell Lymphoma 20%
28. Quality of Life 20%
29. Antineoplastic Agents 20%
30. Uterine Cervical Neoplasms 20%
31. Drug Resistance 20%
32. Ribs 19%
33. Fluorodeoxyglucose F18 19%
34. Glutathione 19%
35. Doppler Ultrasonography 18%
36. Glycolysis 18%
37. Sp1 Transcription Factor 18%
38. Chemoradiotherapy 18%
39. Spine 17%